LongeVC | Latest News & Updates - Mar 04, 2025 Release
LongeVC has backed SiPhox Health, a portfolio company, in its latest funding round as SiPhox doubled its revenue in 2024 and advanced in product development and R&D...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


LongeVC
🌎 longevc.comLongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage biotech and longevity-focused founders, helping them gain industrial momentum, raise capital, and shape the future of the biotech industry. LongeVC aims to build a broad community of biotech innovators by funding companies in complementary sectors and facilitating collaboration among them.
LongeVC - Latest News and Updates
- LongeVC has backed SiPhox Health, a portfolio company, in its latest funding round as SiPhox doubled its revenue in 2024 and advanced in product development and R&D.
- Sergey Jakimov, managing partner at LongeVC, emphasized at the Bioinnovate Symposium that brilliant science alone is insufficient to build a successful biotech business.
- LongeVC's Managing Partner and Head of Investor Relations, Aurora Griffin, will speak at The Livelong Experience event in Palm Beach, Florida, on March 28-29.
- LongeVC will be a Tier 1 sponsor at the 12th Aging Research & Drug Discovery Meeting on August 25-29, 2025, at the University of Copenhagen.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.
